Oncology & Cancer

Genomic sequencing offers new hope for rare cancers

A cancer's genetic sequence may be the key to matching people with rare cancers to the right anti-cancer treatments, according to a new clinical trial instigated by patients.


Roche buys US Foundation Medicine for $2.4 bn

Swiss pharmaceutical giant Roche said Tuesday it had reached an agreement to purchase the remaining shares of US lab Foundation Medicine, of which it already holds a majority stake, for $2.4 billion.

page 1 from 3